Forecast: Healthcare Expenditure on Over-The-Counter Medicines in Poland

The healthcare expenditure on over-the-counter (OTC) medicines in Poland is projected to increase steadily from 2024 to 2028. The expenditure per capita is forecast to grow from €106.42 in 2024 to €118.33 in 2028, reflecting a consistent year-on-year increase.

- Year-on-year variations: - From 2024 to 2025, the expenditure per capita is expected to rise by 2.82%. - From 2025 to 2026, an increase of 2.73% is projected. - For the period of 2026 to 2027, the expenditure is forecast to grow by 2.64%. - From 2027 to 2028, a 2.56% rise is expected.

- The Compound Annual Growth Rate (CAGR) over the period from 2024 to 2028 is approximately 2.68%, indicating steady growth in healthcare expenditure on OTC medicines.

Future trends to watch for include the impact of demographic changes such as an ageing population, increasing health awareness among consumers, and potential regulatory changes in the pharmaceutical sector. Additionally, advancements in e-commerce and digital health platforms may influence consumer purchasing behaviors, impacting overall expenditure trends.